Aadi Bioscience Investor Relations Material
Latest events
Q4 2023
Aadi Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Aadi Bioscience Inc
Access all reports
Aadi Bioscience, Inc. is a clinical stage biopharmaceutical company engaged in the development and commercialization of precision therapies for genetically defined cancers with alterations in mTOR pathway genes. The company develops products designed to treat patients whose cancer can be targeted by specific genetic abnormalities. It focuses on small molecule drugs that utilize bispecific antibody formats as a method of highly targeted cancer therapy. The company was founded in 2007 and is headquartered in Pacific Palisades, California.
Latest articles
Daniel Ek: Co-founder and CEO of Spotify
Explore Daniel Ek's journey from a tech-savvy teenager to the co-founder and CEO of Spotify and the most influential person in the music industry.
28 Mar 2024
Companies That Had Their IPO in 1992: A Cautiously Optimistic Market
1992 marked a relatively cool IPO landscape and stock market sentiment, in the wake of the early 90s recession.
28 Mar 2024
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States